Dr. Malik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
280 East Grand Ave
South San Francisco, CA 94080Phone+1 650-624-3011Fax+1 650-624-3010- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Cardiovascular Disease, 1996 - 2000
- University of California (San Francisco)Residency, Internal Medicine, 1994 - 1996
- University of California San Francisco School of MedicineClass of 1994
Certifications & Licensure
- CA State Medical License 1996 - 2024
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 9 citationsThe effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF).Tor Biering-Sørensen, Masatoshi Minamisawa, Jiankang Liu, Brian Claggett, Alexander Papolos
European Journal of Heart Failure. 2021-04-07 - 10 citationsLetter by Teerlink et al Regarding Article, “Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Res...John R. Teerlink, Fady I. Malik, David A. Kass
Circulation. Heart Failure. 2015-11-01 - 311 citationsCardiac myosin activation with omecamtiv mecarbil in systolic heart failureJohn R. Teerlink, Rafael Diaz, G. Michael Felker, John J.V. McMurray, Marco Metra
The New England Journal of Medicine. 2021-01-14
Journal Articles
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
Press Mentions
- Cytokinetics Presents Positive Results from Cohort 4 of REDWOOD-HCM and Long-Term Results from FOREST-HCM at the American College of Cardiology 72nd Annual Scientific SessionMarch 4th, 2023
- Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022November 7th, 2022
- Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022November 7th, 2022
- Join now to see all
Grant Support
- Validation Of A Novel Sarcomeric High Throughput AssayNational Heart, Lung, And Blood Institute2001
Professional Memberships
- Member
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: